2Spasovski GB,Bervoets AR, Behets GJ,et al.Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.Nephrol Dial Transplant,2003,18(6):1159-1566.
3Cohen-Solal ME,Augry F,Mauras Y,et al.Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.Nephrol Dial Transplant,2002,17(3):449-454.
4Diaz-Corte C,Fernandez-Martin JL,Barreto S,et al.Effect of aluminium load on parathyroid hormone synthesis. Nephrol Dial Transplant,2001,16(4):742-745.
5Malluche H,Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist.Kidney Int,1990,38(2):193-211.
6Rojas E,Carlini RG,Clesca P,et al.The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.Kidney Int,2003,63(5):1915-1923.
7Penalba A,Neme G,Tirado S.Vascular and tissue calcifications of hemodialysis patients. Nefrologia,2003,23(Suppl 2):112-116.
8Lepage R,Roy L,Brossard JH,et al.A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples.Clin Chem,1998,44(4):805-809.
9Coen G,Bonucci E,Ballanti P,et al.PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.Am J Kidney Dis,2002,40(2):348-354.
10Monier-Faugere MC,Geng Z,Mawad H,et al.Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.Kidney Int,2001,60(4):1460-1468.
